A citation-based method for searching scientific literature

Anna Gasinska, Janusz Jaszczynski, Urszula Rychlik, Elżbieta Łuczynska, Marek Pogodzinski, Mikolaj Palaczynski. Pathol Oncol Res 2020
Times Cited: 12







List of co-cited articles
88 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Significance of Glucose Transporter Type 1 (GLUT-1) Expression in the Therapeutic Strategy for Pancreatic Ductal Adenocarcinoma.
Hiroshi Kurahara, Kosei Maemura, Yuko Mataki, Masahiko Sakoda, Satoshi Iino, Yota Kawasaki, Takaaki Arigami, Shinichiro Mori, Yuko Kijima, Shinichi Ueno,[...]. Ann Surg Oncol 2018
21
25

Cellular distribution of Glut-1 and Glut-5 in benign and malignant human prostate tissue.
Karin Reinicke, Paula Sotomayor, Pedro Cisterna, Carolina Delgado, Francisco Nualart, Alejandro Godoy. J Cell Biochem 2012
61
25


Prospective Multicenter Validation of Androgen Receptor Splice Variant 7 and Hormone Therapy Resistance in High-Risk Castration-Resistant Prostate Cancer: The PROPHECY Study.
Andrew J Armstrong, Susan Halabi, Jun Luo, David M Nanus, Paraskevi Giannakakou, Russell Z Szmulewitz, Daniel C Danila, Patrick Healy, Monika Anand, Colin J Rothwell,[...]. J Clin Oncol 2019
178
16

Detection of High-grade Prostate Cancer Using a Urinary Molecular Biomarker-Based Risk Score.
Leander Van Neste, Rianne J Hendriks, Siebren Dijkstra, Geert Trooskens, Erik B Cornel, Sander A Jannink, Hans de Jong, Daphne Hessels, Frank P Smit, Willem J G Melchers,[...]. Eur Urol 2016
198
16

Clinical and Genomic Characterization of Low-Prostate-specific Antigen, High-grade Prostate Cancer.
Brandon A Mahal, David D Yang, Natalie Q Wang, Mohammed Alshalalfa, Elai Davicioni, Voleak Choeurng, Edward M Schaeffer, Ashley E Ross, Daniel E Spratt, Robert B Den,[...]. Eur Urol 2018
55
16

Structured Population-based Prostate-specific Antigen Screening for Prostate Cancer: The European Association of Urology Position in 2019.
Giorgio Gandaglia, Peter Albers, Per-Anders Abrahamsson, Alberto Briganti, James W F Catto, Christopher R Chapple, Francesco Montorsi, Nicolas Mottet, Monique J Roobol, Jens Sønksen,[...]. Eur Urol 2019
48
16

Multicenter evaluation of [-2]proprostate-specific antigen and the prostate health index for detecting prostate cancer.
Carsten Stephan, Sébastien Vincendeau, Alain Houlgatte, Henning Cammann, Klaus Jung, Axel Semjonow. Clin Chem 2013
95
16

The prostate health index PHI predicts oncological outcome and biochemical recurrence after radical prostatectomy - analysis in 437 patients.
Andreas Maxeiner, Ergin Kilic, Julia Matalon, Frank Friedersdorff, Kurt Miller, Klaus Jung, Carsten Stephan, Jonas Busch. Oncotarget 2017
15
16

Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part I: Risk Stratification, Shared Decision Making, and Care Options.
Martin G Sanda, Jeffrey A Cadeddu, Erin Kirkby, Ronald C Chen, Tony Crispino, Joann Fontanarosa, Stephen J Freedland, Kirsten Greene, Laurence H Klotz, Danil V Makarov,[...]. J Urol 2018
411
16

Prognostic role of Ki-67 score in localized prostate cancer: A systematic review and meta-analysis.
Alejandro Berlin, Julio F Castro-Mesta, Laura Rodriguez-Romo, David Hernandez-Barajas, Juan F González-Guerrero, Iván A Rodríguez-Fernández, Galileo González-Conchas, Adrian Verdines-Perez, Francisco E Vera-Badillo. Urol Oncol 2017
36
16

Head-to-head comparison of prostate health index and urinary PCA3 for predicting cancer at initial or repeat biopsy.
Vincenzo Scattoni, Massimo Lazzeri, Giovanni Lughezzani, Stefano De Luca, Roberto Passera, Enrico Bollito, Donato Randone, Firas Abdollah, Umberto Capitanio, Alessandro Larcher,[...]. J Urol 2013
75
16

Development and clinical validation of an in situ biopsy-based multimarker assay for risk stratification in prostate cancer.
Peter Blume-Jensen, David M Berman, David L Rimm, Michail Shipitsin, Mathew Putzi, Thomas P Nifong, Clayton Small, Sibgat Choudhury, Teresa Capela, Louis Coupal,[...]. Clin Cancer Res 2015
101
16

Optimizing Anticancer Therapy in Metastatic Non-Castrate Prostate Cancer: American Society of Clinical Oncology Clinical Practice Guideline.
Michael J Morris, R Bryan Rumble, Ethan Basch, Sebastien J Hotte, Andrew Loblaw, Dana Rathkopf, Paul Celano, Rick Bangs, Matthew I Milowsky. J Clin Oncol 2018
43
16

Cancer screening in the United States, 2018: A review of current American Cancer Society guidelines and current issues in cancer screening.
Robert A Smith, Kimberly S Andrews, Durado Brooks, Stacey A Fedewa, Deana Manassaram-Baptiste, Debbie Saslow, Otis W Brawley, Richard C Wender. CA Cancer J Clin 2018
264
16


Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement.
David C Grossman, Susan J Curry, Douglas K Owens, Kirsten Bibbins-Domingo, Aaron B Caughey, Karina W Davidson, Chyke A Doubeni, Mark Ebell, John W Epling, Alex R Kemper,[...]. JAMA 2018
503
16

The prostate health index selectively identifies clinically significant prostate cancer.
Stacy Loeb, Martin G Sanda, Dennis L Broyles, Sanghyuk S Shin, Chris H Bangma, John T Wei, Alan W Partin, George G Klee, Kevin M Slawin, Leonard S Marks,[...]. J Urol 2015
155
16

Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men With Metastatic Castration-Resistant Prostate Cancer Treated With First- and Second-Line Abiraterone and Enzalutamide.
Emmanuel S Antonarakis, Changxue Lu, Brandon Luber, Hao Wang, Yan Chen, Yezi Zhu, John L Silberstein, Maritza N Taylor, Benjamin L Maughan, Samuel R Denmeade,[...]. J Clin Oncol 2017
290
16

A Biopsy-based 17-gene Genomic Prostate Score Predicts Recurrence After Radical Prostatectomy and Adverse Surgical Pathology in a Racially Diverse Population of Men with Clinically Low- and Intermediate-risk Prostate Cancer.
Jennifer Cullen, Inger L Rosner, Timothy C Brand, Nan Zhang, Athanasios C Tsiatis, Joel Moncur, Amina Ali, Yongmei Chen, Dejan Knezevic, Tara Maddala,[...]. Eur Urol 2015
198
16

Natural history of progression after PSA elevation following radical prostatectomy.
C R Pound, A W Partin, M A Eisenberger, D W Chan, J D Pearson, P C Walsh. JAMA 1999
16

Prostate-specific antigen (PSA) isoform p2PSA in combination with total PSA and free PSA improves diagnostic accuracy in prostate cancer detection.
Flip H Jansen, Ron H N van Schaik, Joep Kurstjens, Wolfgang Horninger, Helmut Klocker, Jasmin Bektic, Mark F Wildhagen, Monique J Roobol, Chris H Bangma, Georg Bartsch. Eur Urol 2010
175
16

PSA bounces after neoadjuvant androgen deprivation and external beam radiation: impact on definitions of failure.
Anthony L Zietman, John P Christodouleas, William U Shipley. Int J Radiat Oncol Biol Phys 2005
36
16

The Prostate Health Index adds predictive value to multi-parametric MRI in detecting significant prostate cancers in a repeat biopsy population.
V J Gnanapragasam, K Burling, A George, S Stearn, A Warren, T Barrett, B Koo, F A Gallagher, A Doble, C Kastner,[...]. Sci Rep 2016
49
16

Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial.
W J Catalona, A W Partin, K M Slawin, M K Brawer, R C Flanigan, A Patel, J P Richie, J B deKernion, P C Walsh, P T Scardino,[...]. JAMA 1998
777
16

Intratumoral and Intertumoral Genomic Heterogeneity of Multifocal Localized Prostate Cancer Impacts Molecular Classifications and Genomic Prognosticators.
Lei Wei, Jianmin Wang, Erika Lampert, Simon Schlanger, Adam D DePriest, Qiang Hu, Eduardo Cortes Gomez, Mitsuko Murakam, Sean T Glenn, Jeffrey Conroy,[...]. Eur Urol 2017
131
16

The Memorial Sloan Kettering Cancer Center Recommendations for Prostate Cancer Screening.
Andrew J Vickers, James A Eastham, Peter T Scardino, Hans Lilja. Urology 2016
45
16


A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden.
Andrew J Vickers, Angel M Cronin, Gunnar Aus, Carl-Gustav Pihl, Charlotte Becker, Kim Pettersson, Peter T Scardino, Jonas Hugosson, Hans Lilja. BMC Med 2008
169
16

Seven-Month Prostate-Specific Antigen Is Prognostic in Metastatic Hormone-Sensitive Prostate Cancer Treated With Androgen Deprivation With or Without Docetaxel.
Lauren C Harshman, Yu-Hui Chen, Glenn Liu, Michael A Carducci, David Jarrard, Robert Dreicer, Noah Hahn, Jorge A Garcia, Maha Hussain, Daniel Shevrin,[...]. J Clin Oncol 2018
44
16


A Four-kallikrein Panel Predicts High-grade Cancer on Biopsy: Independent Validation in a Community Cohort.
Katharina Braun, Daniel D Sjoberg, Andrew J Vickers, Hans Lilja, Anders S Bjartell. Eur Urol 2016
61
16

Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis.
Shuang G Zhao, S Laura Chang, Daniel E Spratt, Nicholas Erho, Menggang Yu, Hussam Al-Deen Ashab, Mohammed Alshalalfa, Corey Speers, Scott A Tomlins, Elai Davicioni,[...]. Lancet Oncol 2016
128
16


AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer.
Emmanuel S Antonarakis, Changxue Lu, Hao Wang, Brandon Luber, Mary Nakazawa, Jeffrey C Roeser, Yan Chen, Tabrez A Mohammad, Yidong Chen, Helen L Fedor,[...]. N Engl J Med 2014
16

EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.
Nicolas Mottet, Joaquim Bellmunt, Michel Bolla, Erik Briers, Marcus G Cumberbatch, Maria De Santis, Nicola Fossati, Tobias Gross, Ann M Henry, Steven Joniau,[...]. Eur Urol 2017
16

Can urinary PCA3 supplement PSA in the early detection of prostate cancer?
John T Wei, Ziding Feng, Alan W Partin, Elissa Brown, Ian Thompson, Lori Sokoll, Daniel W Chan, Yair Lotan, Adam S Kibel, J Erik Busby,[...]. J Clin Oncol 2014
170
16

APTIMA PCA3 molecular urine test: development of a method to aid in the diagnosis of prostate cancer.
Jack Groskopf, Sheila M J Aubin, Ina Lim Deras, Amy Blase, Sharon Bodrug, Craig Clark, Steven Brentano, Jeannette Mathis, Jimmykim Pham, Troels Meyer,[...]. Clin Chem 2006
361
16

A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling.
Eric A Klein, Matthew R Cooperberg, Cristina Magi-Galluzzi, Jeffry P Simko, Sara M Falzarano, Tara Maddala, June M Chan, Jianbo Li, Janet E Cowan, Athanasios C Tsiatis,[...]. Eur Urol 2014
405
16

Absolute prostate-specific antigen value after androgen deprivation is a strong independent predictor of survival in new metastatic prostate cancer: data from Southwest Oncology Group Trial 9346 (INT-0162).
Maha Hussain, Catherine M Tangen, Celestia Higano, Paul F Schelhammer, James Faulkner, E David Crawford, George Wilding, Atif Akdas, Eric J Small, Bryan Donnelly,[...]. J Clin Oncol 2006
314
16

Serum isoform [-2]proPSA derivatives significantly improve prediction of prostate cancer at initial biopsy in a total PSA range of 2-10 ng/ml: a multicentric European study.
Massimo Lazzeri, Alexander Haese, Alexandre de la Taille, Joan Palou Redorta, Thomas McNicholas, Giovanni Lughezzani, Vincenzo Scattoni, Vittorio Bini, Massimo Freschi, Amy Sussman,[...]. Eur Urol 2013
142
16

Prostate cancer screening in men aged 50-69 years (STHLM3): a prospective population-based diagnostic study.
Henrik Grönberg, Jan Adolfsson, Markus Aly, Tobias Nordström, Peter Wiklund, Yvonne Brandberg, James Thompson, Fredrik Wiklund, Johan Lindberg, Mark Clements,[...]. Lancet Oncol 2015
217
16

Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3.
Howard I Scher, Michael J Morris, Walter M Stadler, Celestia Higano, Ethan Basch, Karim Fizazi, Emmanuel S Antonarakis, Tomasz M Beer, Michael A Carducci, Kim N Chi,[...]. J Clin Oncol 2016
694
16

Evaluation of New Tests and Interventions for Prostate Cancer Management: A Systematic Review.
Ghadeer Olleik, Wassim Kassouf, Armen Aprikian, Jason Hu, Marie Vanhuyse, Fabio Cury, Stuart Peacock, Elin Bonnevier, Ebba Palenius, Alice Dragomir. J Natl Compr Canc Netw 2018
18
16

epiCaPture: A Urine DNA Methylation Test for Early Detection of Aggressive Prostate Cancer.
Eve O'Reilly, Alexandra V Tuzova, Anna L Walsh, Niamh M Russell, Odharnaith O'Brien, Sarah Kelly, Odharna Ni Dhomhnallain, Liam DeBarra, Connie M Dale, Rick Brugman,[...]. JCO Precis Oncol 2019
26
16

Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference.
Mack Roach, Gerald Hanks, Howard Thames, Paul Schellhammer, William U Shipley, Gerald H Sokol, Howard Sandler. Int J Radiat Oncol Biol Phys 2006
16

Patterns and fate of PSA bouncing following 3D-CRT.
A L Hanlon, W H Pinover, E M Horwitz, G E Hanks. Int J Radiat Oncol Biol Phys 2001
88
16

Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial.
Gillian M Duchesne, Henry H Woo, Julie K Bassett, Steven J Bowe, Catherine D'Este, Mark Frydenberg, Madeleine King, Leo Ledwich, Andrew Loblaw, Shawn Malone,[...]. Lancet Oncol 2016
134
16

PCA3 in prostate cancer and tumor aggressiveness detection on 407 high-risk patients: a National Cancer Institute experience.
Roberta Merola, Luigi Tomao, Anna Antenucci, Isabella Sperduti, Steno Sentinelli, Serena Masi, Chiara Mandoj, Giulia Orlandi, Rocco Papalia, Salvatore Guaglianone,[...]. J Exp Clin Cancer Res 2015
46
16

Preoperative prostate health index is an independent predictor of early biochemical recurrence after radical prostatectomy: Results from a prospective single-center study.
Giovanni Lughezzani, Massimo Lazzeri, Nicolò Maria Buffi, Alberto Abrate, Francesco Alessandro Mistretta, Rodolfo Hurle, Luisa Pasini, Luigi Castaldo, Silvia Zandegiacomo De Zorzi, Roberto Peschechera,[...]. Urol Oncol 2015
15
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.